T Cell Biomarker Predicts Which CLL Patients will Respond to CAR T Cell Therapy – Scicasts (press release) (blog)
Scicasts (press release) (blog) |
T Cell Biomarker Predicts Which CLL Patients will Respond to CAR T Cell Therapy
Scicasts (press release) (blog) While 80 percent of patients with advanced acute lymphoblastic leukemia (ALL) treated with the CAR T cell therapy now known as Kymriah™ have a dramatic response, only 26 percent of CLL patients respond to it in clinical trials. A new study from the … T-Cell Biomarker Predicts Which CLL Patients Will Respond to CAR … Healthy T cells have a fighting chance for cell therapy | Penn Today |
